共 31 条
[1]
Marcus, Surveillance of health-care workers exposed to blood from patients infected with human immunodeficiency virus, N Engl J Med, 319, pp. 1118-1123, (1988)
[2]
McCray, Occupational risk of the acquired immunodeficiency syndrome among health care workers, N Engl J Med, 314, pp. 1127-1132, (1986)
[3]
Tokars, Marcus, Culver, McKibben, Bell, Zidovudine (AZT) after occupational exposure to HIV-infected blood, Programs and abstracts of the sixth international conference on AIDS, (1990)
[4]
Henderson, Fahey, Willy, Et al., Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures: a prospective evaluation, Ann Intern Med, 113, pp. 740-746, (1990)
[5]
Gerberding, Littell, Chambers, Et al., Risk of occupational HIV transmission in intensely exposed health-care workers: follow-up, Program and abstracts of the twenty-eighth interscience conference on antimicrobial agents and chemotherapy, (1988)
[6]
Elmshe, Mulligan, O'Shaughnessy, National surveillance program: occupational exposure to human immunodeficiency virus (HIV-1) infection in Canada, Program and abstracts of the fifth international conference on AIDS, (1989)
[7]
Centers for Disease Control, Update: human immunodeficiency virus infections in health-care workers exposed to blood of infected patients, MMWR, 36, pp. 285-289, (1987)
[8]
Haley, Reff, Murphy, Report of a possible laboratory acquired HIV infection, Program and abstracts of the fifth international conference on AIDS, (1989)
[9]
Centers for Disease Control, Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace, MMWR, 34, pp. 681-686, (1985)
[10]
Centers for Disease Control, Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace, MMWR, 34, pp. 691-695, (1985)